nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—HTR7—epilepsy syndrome	0.11	0.355	CbGaD
Iloperidone—ADRA2A—epilepsy syndrome	0.0944	0.304	CbGaD
Iloperidone—HTR2A—epilepsy syndrome	0.0554	0.178	CbGaD
Iloperidone—CYP2D6—epilepsy syndrome	0.0506	0.163	CbGaD
Iloperidone—CYP2E1—Trimethadione—epilepsy syndrome	0.0179	0.0478	CbGbCtD
Iloperidone—CYP2E1—Felbamate—epilepsy syndrome	0.0179	0.0478	CbGbCtD
Iloperidone—CYP2E1—Clonazepam—epilepsy syndrome	0.0152	0.0407	CbGbCtD
Iloperidone—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.0149	0.04	CbGbCtD
Iloperidone—CYP3A7—Carbamazepine—epilepsy syndrome	0.0125	0.0335	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.0125	0.0335	CbGbCtD
Iloperidone—CYP2E1—Rufinamide—epilepsy syndrome	0.0124	0.0332	CbGbCtD
Iloperidone—CYP3A7—Phenytoin—epilepsy syndrome	0.0112	0.03	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.0112	0.03	CbGbCtD
Iloperidone—CYP2E1—Propofol—epilepsy syndrome	0.0101	0.027	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00999	0.0268	CbGbCtD
Iloperidone—CYP3A7—Phenobarbital—epilepsy syndrome	0.00999	0.0268	CbGbCtD
Iloperidone—CYP3A7—Midazolam—epilepsy syndrome	0.00985	0.0264	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00985	0.0264	CbGbCtD
Iloperidone—CYP2E1—Phenobarbital—epilepsy syndrome	0.00965	0.0258	CbGbCtD
Iloperidone—CYP2E1—Midazolam—epilepsy syndrome	0.00951	0.0255	CbGbCtD
Iloperidone—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00947	0.0254	CbGbCtD
Iloperidone—CYP3A7—Diazepam—epilepsy syndrome	0.00947	0.0254	CbGbCtD
Iloperidone—CYP3A5—Carbamazepine—epilepsy syndrome	0.00938	0.0251	CbGbCtD
Iloperidone—CYP2E1—Diazepam—epilepsy syndrome	0.00915	0.0245	CbGbCtD
Iloperidone—CYP3A5—Phenytoin—epilepsy syndrome	0.00841	0.0225	CbGbCtD
Iloperidone—CYP3A5—Phenobarbital—epilepsy syndrome	0.0075	0.0201	CbGbCtD
Iloperidone—CYP3A5—Midazolam—epilepsy syndrome	0.00739	0.0198	CbGbCtD
Iloperidone—CYP3A5—Diazepam—epilepsy syndrome	0.00711	0.019	CbGbCtD
Iloperidone—CYP1A2—Carbamazepine—epilepsy syndrome	0.00698	0.0187	CbGbCtD
Iloperidone—CYP1A2—Primidone—epilepsy syndrome	0.00652	0.0174	CbGbCtD
Iloperidone—CYP1A2—Propofol—epilepsy syndrome	0.00584	0.0156	CbGbCtD
Iloperidone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00582	0.0156	CbGbCtD
Iloperidone—CYP3A5—Valproic Acid—epilepsy syndrome	0.0056	0.015	CbGbCtD
Iloperidone—CYP1A2—Phenobarbital—epilepsy syndrome	0.00558	0.0149	CbGbCtD
Iloperidone—CYP3A4—Felbamate—epilepsy syndrome	0.00541	0.0145	CbGbCtD
Iloperidone—CYP3A4—Trimethadione—epilepsy syndrome	0.00541	0.0145	CbGbCtD
Iloperidone—CYP1A2—Diazepam—epilepsy syndrome	0.00529	0.0142	CbGbCtD
Iloperidone—HTR1D—meninx—epilepsy syndrome	0.00522	0.0875	CbGeAlD
Iloperidone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00509	0.0136	CbGbCtD
Iloperidone—CYP2D6—Propofol—epilepsy syndrome	0.00481	0.0129	CbGbCtD
Iloperidone—CYP3A4—Clonazepam—epilepsy syndrome	0.0046	0.0123	CbGbCtD
Iloperidone—CYP3A4—Clobazam—epilepsy syndrome	0.00441	0.0118	CbGbCtD
Iloperidone—CYP1A2—Valproic Acid—epilepsy syndrome	0.00417	0.0112	CbGbCtD
Iloperidone—CYP3A4—Rufinamide—epilepsy syndrome	0.00375	0.01	CbGbCtD
Iloperidone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00366	0.00979	CbGbCtD
Iloperidone—CYP3A4—Primidone—epilepsy syndrome	0.00341	0.00914	CbGbCtD
Iloperidone—CYP3A4—Phenytoin—epilepsy syndrome	0.00328	0.00878	CbGbCtD
Iloperidone—CYP3A4—Propofol—epilepsy syndrome	0.00306	0.00819	CbGbCtD
Iloperidone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00292	0.00783	CbGbCtD
Iloperidone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00292	0.00783	CbGbCtD
Iloperidone—CYP3A4—Midazolam—epilepsy syndrome	0.00288	0.00772	CbGbCtD
Iloperidone—HTR2A—phrenic nerve—epilepsy syndrome	0.00281	0.0471	CbGeAlD
Iloperidone—CYP3A4—Diazepam—epilepsy syndrome	0.00277	0.00742	CbGbCtD
Iloperidone—CYP3A4—Zonisamide—epilepsy syndrome	0.0027	0.00724	CbGbCtD
Iloperidone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00218	0.00585	CbGbCtD
Iloperidone—DRD3—telencephalic ventricle—epilepsy syndrome	0.00213	0.0357	CbGeAlD
Iloperidone—HTR7—locus ceruleus—epilepsy syndrome	0.00201	0.0337	CbGeAlD
Iloperidone—CYP3A4—Topiramate—epilepsy syndrome	0.00197	0.00528	CbGbCtD
Iloperidone—HTR7—vagus nerve—epilepsy syndrome	0.00154	0.0258	CbGeAlD
Iloperidone—DRD1—telencephalic ventricle—epilepsy syndrome	0.00152	0.0256	CbGeAlD
Iloperidone—HTR6—ganglion—epilepsy syndrome	0.00128	0.0214	CbGeAlD
Iloperidone—HTR2A—locus ceruleus—epilepsy syndrome	0.00125	0.021	CbGeAlD
Iloperidone—HTR1D—telencephalic ventricle—epilepsy syndrome	0.0012	0.0201	CbGeAlD
Iloperidone—HTR2C—telencephalic ventricle—epilepsy syndrome	0.00118	0.0199	CbGeAlD
Iloperidone—HTR7—pons—epilepsy syndrome	0.00116	0.0194	CbGeAlD
Iloperidone—HTR7—autonomic nervous system—epilepsy syndrome	0.00107	0.0179	CbGeAlD
Iloperidone—HTR2A—cerebellar cortex—epilepsy syndrome	0.00102	0.0171	CbGeAlD
Iloperidone—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000997	0.0167	CbGeAlD
Iloperidone—HTR2A—vagus nerve—epilepsy syndrome	0.000959	0.0161	CbGeAlD
Iloperidone—HTR7—telencephalic ventricle—epilepsy syndrome	0.000953	0.016	CbGeAlD
Iloperidone—DRD1—ganglion—epilepsy syndrome	0.000949	0.0159	CbGeAlD
Iloperidone—DRD2—telencephalic ventricle—epilepsy syndrome	0.000901	0.0151	CbGeAlD
Iloperidone—HTR1D—ganglion—epilepsy syndrome	0.000744	0.0125	CbGeAlD
Iloperidone—HTR2C—ganglion—epilepsy syndrome	0.000737	0.0124	CbGeAlD
Iloperidone—HTR2A—pons—epilepsy syndrome	0.000722	0.0121	CbGeAlD
Iloperidone—HTR2A—autonomic nervous system—epilepsy syndrome	0.000666	0.0112	CbGeAlD
Iloperidone—HTR1A—ganglion—epilepsy syndrome	0.000621	0.0104	CbGeAlD
Iloperidone—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000594	0.00997	CbGeAlD
Iloperidone—HTR7—ganglion—epilepsy syndrome	0.000593	0.00995	CbGeAlD
Iloperidone—DRD2—ganglion—epilepsy syndrome	0.000561	0.00941	CbGeAlD
Iloperidone—HTR6—forebrain—epilepsy syndrome	0.000535	0.00898	CbGeAlD
Iloperidone—HTR6—telencephalon—epilepsy syndrome	0.000492	0.00826	CbGeAlD
Iloperidone—HTR1A—hindbrain—epilepsy syndrome	0.000471	0.0079	CbGeAlD
Iloperidone—HTR7—hindbrain—epilepsy syndrome	0.00045	0.00755	CbGeAlD
Iloperidone—ADRA1A—hindbrain—epilepsy syndrome	0.000434	0.00728	CbGeAlD
Iloperidone—DRD2—hindbrain—epilepsy syndrome	0.000425	0.00713	CbGeAlD
Iloperidone—DRD1—brainstem—epilepsy syndrome	0.000413	0.00692	CbGeAlD
Iloperidone—DRD1—forebrain—epilepsy syndrome	0.000398	0.00668	CbGeAlD
Iloperidone—Paliperidone—ADRA2A—epilepsy syndrome	0.000373	0.129	CrCbGaD
Iloperidone—HTR2A—ganglion—epilepsy syndrome	0.00037	0.0062	CbGeAlD
Iloperidone—DRD1—telencephalon—epilepsy syndrome	0.000366	0.00614	CbGeAlD
Iloperidone—DRD4—brain—epilepsy syndrome	0.000328	0.00551	CbGeAlD
Iloperidone—Risperidone—HTR7—epilepsy syndrome	0.000324	0.112	CrCbGaD
Iloperidone—HTR1D—brainstem—epilepsy syndrome	0.000324	0.00543	CbGeAlD
Iloperidone—HTR2C—brainstem—epilepsy syndrome	0.00032	0.00538	CbGeAlD
Iloperidone—DRD3—head—epilepsy syndrome	0.000318	0.00534	CbGeAlD
Iloperidone—HTR1D—forebrain—epilepsy syndrome	0.000312	0.00524	CbGeAlD
Iloperidone—HTR2C—forebrain—epilepsy syndrome	0.000309	0.00519	CbGeAlD
Iloperidone—HTR6—head—epilepsy syndrome	0.000306	0.00514	CbGeAlD
Iloperidone—DRD3—nervous system—epilepsy syndrome	0.000302	0.00506	CbGeAlD
Iloperidone—DRD3—central nervous system—epilepsy syndrome	0.000291	0.00488	CbGeAlD
Iloperidone—HTR6—nervous system—epilepsy syndrome	0.000291	0.00487	CbGeAlD
Iloperidone—HTR1D—telencephalon—epilepsy syndrome	0.000287	0.00482	CbGeAlD
Iloperidone—HTR2C—telencephalon—epilepsy syndrome	0.000284	0.00477	CbGeAlD
Iloperidone—HTR2A—hindbrain—epilepsy syndrome	0.00028	0.00471	CbGeAlD
Iloperidone—HTR6—central nervous system—epilepsy syndrome	0.00028	0.00469	CbGeAlD
Iloperidone—Risperidone—ADRA2A—epilepsy syndrome	0.000278	0.0962	CrCbGaD
Iloperidone—HTR1A—brainstem—epilepsy syndrome	0.00027	0.00453	CbGeAlD
Iloperidone—SIGMAR1—telencephalon—epilepsy syndrome	0.000268	0.00449	CbGeAlD
Iloperidone—DRD1—midbrain—epilepsy syndrome	0.000263	0.00441	CbGeAlD
Iloperidone—HTR1A—forebrain—epilepsy syndrome	0.00026	0.00437	CbGeAlD
Iloperidone—HTR7—brainstem—epilepsy syndrome	0.000258	0.00433	CbGeAlD
Iloperidone—CYP2D6—hindbrain—epilepsy syndrome	0.000256	0.00429	CbGeAlD
Iloperidone—HTR7—forebrain—epilepsy syndrome	0.000249	0.00417	CbGeAlD
Iloperidone—ADRA1A—brainstem—epilepsy syndrome	0.000249	0.00417	CbGeAlD
Iloperidone—DRD2—brainstem—epilepsy syndrome	0.000244	0.00409	CbGeAlD
Iloperidone—ADRA1A—forebrain—epilepsy syndrome	0.00024	0.00403	CbGeAlD
Iloperidone—HTR1A—telencephalon—epilepsy syndrome	0.000239	0.00402	CbGeAlD
Iloperidone—DRD2—forebrain—epilepsy syndrome	0.000235	0.00395	CbGeAlD
Iloperidone—DRD3—brain—epilepsy syndrome	0.000231	0.00387	CbGeAlD
Iloperidone—HTR7—telencephalon—epilepsy syndrome	0.000229	0.00384	CbGeAlD
Iloperidone—DRD1—head—epilepsy syndrome	0.000228	0.00382	CbGeAlD
Iloperidone—HTR2C—medulla oblongata—epilepsy syndrome	0.000223	0.00375	CbGeAlD
Iloperidone—HTR6—brain—epilepsy syndrome	0.000222	0.00373	CbGeAlD
Iloperidone—ADRA1A—telencephalon—epilepsy syndrome	0.000221	0.0037	CbGeAlD
Iloperidone—Paliperidone—HTR2A—epilepsy syndrome	0.000219	0.0756	CrCbGaD
Iloperidone—DRD2—telencephalon—epilepsy syndrome	0.000216	0.00363	CbGeAlD
Iloperidone—DRD1—nervous system—epilepsy syndrome	0.000216	0.00363	CbGeAlD
Iloperidone—SIGMAR1—medulla oblongata—epilepsy syndrome	0.00021	0.00353	CbGeAlD
Iloperidone—ADRA2C—telencephalon—epilepsy syndrome	0.00021	0.00353	CbGeAlD
Iloperidone—DRD1—central nervous system—epilepsy syndrome	0.000208	0.00349	CbGeAlD
Iloperidone—HTR1D—midbrain—epilepsy syndrome	0.000206	0.00346	CbGeAlD
Iloperidone—Cisapride—CYP2C19—epilepsy syndrome	0.000204	0.0707	CrCbGaD
Iloperidone—HTR2C—midbrain—epilepsy syndrome	0.000204	0.00343	CbGeAlD
Iloperidone—Paliperidone—CYP2D6—epilepsy syndrome	0.0002	0.0692	CrCbGaD
Iloperidone—HTR2C—spinal cord—epilepsy syndrome	0.000199	0.00334	CbGeAlD
Iloperidone—SIGMAR1—midbrain—epilepsy syndrome	0.000192	0.00323	CbGeAlD
Iloperidone—SIGMAR1—spinal cord—epilepsy syndrome	0.000188	0.00315	CbGeAlD
Iloperidone—HRH1—forebrain—epilepsy syndrome	0.000186	0.00312	CbGeAlD
Iloperidone—ADRA2A—forebrain—epilepsy syndrome	0.000182	0.00306	CbGeAlD
Iloperidone—HTR7—medulla oblongata—epilepsy syndrome	0.00018	0.00302	CbGeAlD
Iloperidone—HTR1D—head—epilepsy syndrome	0.000179	0.003	CbGeAlD
Iloperidone—HTR2C—head—epilepsy syndrome	0.000177	0.00297	CbGeAlD
Iloperidone—Gefitinib—ABCG2—epilepsy syndrome	0.000173	0.0598	CrCbGaD
Iloperidone—HTR1A—midbrain—epilepsy syndrome	0.000172	0.00288	CbGeAlD
Iloperidone—HRH1—telencephalon—epilepsy syndrome	0.000171	0.00287	CbGeAlD
Iloperidone—HTR1D—nervous system—epilepsy syndrome	0.00017	0.00284	CbGeAlD
Iloperidone—HTR2C—nervous system—epilepsy syndrome	0.000168	0.00282	CbGeAlD
Iloperidone—ADRA2A—telencephalon—epilepsy syndrome	0.000168	0.00282	CbGeAlD
Iloperidone—HTR1A—spinal cord—epilepsy syndrome	0.000168	0.00281	CbGeAlD
Iloperidone—Cisapride—HTR2A—epilepsy syndrome	0.000166	0.0573	CrCbGaD
Iloperidone—ADRA2C—medulla oblongata—epilepsy syndrome	0.000165	0.00277	CbGeAlD
Iloperidone—DRD1—brain—epilepsy syndrome	0.000165	0.00277	CbGeAlD
Iloperidone—HTR7—midbrain—epilepsy syndrome	0.000164	0.00276	CbGeAlD
Iloperidone—CYP2E1—telencephalon—epilepsy syndrome	0.000164	0.00275	CbGeAlD
Iloperidone—HTR1D—central nervous system—epilepsy syndrome	0.000163	0.00274	CbGeAlD
Iloperidone—Risperidone—HTR2A—epilepsy syndrome	0.000163	0.0564	CrCbGaD
Iloperidone—HTR2C—central nervous system—epilepsy syndrome	0.000162	0.00271	CbGeAlD
Iloperidone—HTR2A—brainstem—epilepsy syndrome	0.000161	0.0027	CbGeAlD
Iloperidone—HTR7—spinal cord—epilepsy syndrome	0.00016	0.00269	CbGeAlD
Iloperidone—DRD2—midbrain—epilepsy syndrome	0.000155	0.00261	CbGeAlD
Iloperidone—HTR2A—forebrain—epilepsy syndrome	0.000155	0.0026	CbGeAlD
Iloperidone—Cisapride—CYP2D6—epilepsy syndrome	0.000152	0.0524	CrCbGaD
Iloperidone—ADRA2C—midbrain—epilepsy syndrome	0.000151	0.00253	CbGeAlD
Iloperidone—Risperidone—CYP2D6—epilepsy syndrome	0.000149	0.0516	CrCbGaD
Iloperidone—HTR1A—head—epilepsy syndrome	0.000149	0.0025	CbGeAlD
Iloperidone—SIGMAR1—cerebellum—epilepsy syndrome	0.000149	0.0025	CbGeAlD
Iloperidone—ADRA2C—spinal cord—epilepsy syndrome	0.000147	0.00247	CbGeAlD
Iloperidone—CYP2D6—brainstem—epilepsy syndrome	0.000146	0.00246	CbGeAlD
Iloperidone—HTR2A—telencephalon—epilepsy syndrome	0.000143	0.00239	CbGeAlD
Iloperidone—HTR7—head—epilepsy syndrome	0.000142	0.00239	CbGeAlD
Iloperidone—CYP2D6—forebrain—epilepsy syndrome	0.000141	0.00237	CbGeAlD
Iloperidone—HTR1A—nervous system—epilepsy syndrome	0.000141	0.00237	CbGeAlD
Iloperidone—ADRA1A—head—epilepsy syndrome	0.000137	0.00231	CbGeAlD
Iloperidone—HTR1A—central nervous system—epilepsy syndrome	0.000136	0.00228	CbGeAlD
Iloperidone—Gefitinib—CYP2C19—epilepsy syndrome	0.000136	0.047	CrCbGaD
Iloperidone—HTR7—nervous system—epilepsy syndrome	0.000135	0.00227	CbGeAlD
Iloperidone—DRD2—head—epilepsy syndrome	0.000135	0.00226	CbGeAlD
Iloperidone—HTR1A—cerebellum—epilepsy syndrome	0.000133	0.00223	CbGeAlD
Iloperidone—ADRA2A—medulla oblongata—epilepsy syndrome	0.000132	0.00221	CbGeAlD
Iloperidone—ADRA2C—head—epilepsy syndrome	0.000131	0.0022	CbGeAlD
Iloperidone—ADRA1A—nervous system—epilepsy syndrome	0.00013	0.00219	CbGeAlD
Iloperidone—HTR7—central nervous system—epilepsy syndrome	0.00013	0.00218	CbGeAlD
Iloperidone—CYP2D6—telencephalon—epilepsy syndrome	0.00013	0.00218	CbGeAlD
Iloperidone—HTR1D—brain—epilepsy syndrome	0.00013	0.00217	CbGeAlD
Iloperidone—CYP2E1—medulla oblongata—epilepsy syndrome	0.000129	0.00216	CbGeAlD
Iloperidone—HTR2C—brain—epilepsy syndrome	0.000128	0.00215	CbGeAlD
Iloperidone—DRD2—nervous system—epilepsy syndrome	0.000128	0.00214	CbGeAlD
Iloperidone—HTR7—cerebellum—epilepsy syndrome	0.000127	0.00213	CbGeAlD
Iloperidone—ADRA1A—central nervous system—epilepsy syndrome	0.000125	0.0021	CbGeAlD
Iloperidone—ADRA2C—nervous system—epilepsy syndrome	0.000124	0.00208	CbGeAlD
Iloperidone—DRD2—central nervous system—epilepsy syndrome	0.000123	0.00206	CbGeAlD
Iloperidone—ADRA1A—cerebellum—epilepsy syndrome	0.000123	0.00206	CbGeAlD
Iloperidone—SIGMAR1—brain—epilepsy syndrome	0.000121	0.00203	CbGeAlD
Iloperidone—ADRA2A—midbrain—epilepsy syndrome	0.00012	0.00202	CbGeAlD
Iloperidone—DRD2—cerebellum—epilepsy syndrome	0.00012	0.00202	CbGeAlD
Iloperidone—ADRA2C—central nervous system—epilepsy syndrome	0.00012	0.00201	CbGeAlD
Iloperidone—ADRA2A—spinal cord—epilepsy syndrome	0.000118	0.00197	CbGeAlD
Iloperidone—ADRA2C—cerebellum—epilepsy syndrome	0.000117	0.00196	CbGeAlD
Iloperidone—CYP2E1—spinal cord—epilepsy syndrome	0.000115	0.00193	CbGeAlD
Iloperidone—HTR2A—medulla oblongata—epilepsy syndrome	0.000112	0.00188	CbGeAlD
Iloperidone—HTR1A—brain—epilepsy syndrome	0.000108	0.00181	CbGeAlD
Iloperidone—Risperidone—ABCB1—epilepsy syndrome	0.000107	0.0368	CrCbGaD
Iloperidone—HRH1—head—epilepsy syndrome	0.000106	0.00178	CbGeAlD
Iloperidone—ADRA2A—head—epilepsy syndrome	0.000104	0.00175	CbGeAlD
Iloperidone—HTR7—brain—epilepsy syndrome	0.000103	0.00173	CbGeAlD
Iloperidone—HTR2A—midbrain—epilepsy syndrome	0.000102	0.00172	CbGeAlD
Iloperidone—CYP2E1—head—epilepsy syndrome	0.000102	0.00171	CbGeAlD
Iloperidone—HRH1—nervous system—epilepsy syndrome	0.000101	0.00169	CbGeAlD
Iloperidone—Gefitinib—CYP2D6—epilepsy syndrome	0.000101	0.0348	CrCbGaD
Iloperidone—HTR2A—spinal cord—epilepsy syndrome	0.0001	0.00168	CbGeAlD
Iloperidone—ADRA1A—brain—epilepsy syndrome	9.96e-05	0.00167	CbGeAlD
Iloperidone—ADRA2A—nervous system—epilepsy syndrome	9.91e-05	0.00166	CbGeAlD
Iloperidone—DRD2—brain—epilepsy syndrome	9.76e-05	0.00164	CbGeAlD
Iloperidone—HRH1—central nervous system—epilepsy syndrome	9.71e-05	0.00163	CbGeAlD
Iloperidone—CYP2E1—nervous system—epilepsy syndrome	9.69e-05	0.00163	CbGeAlD
Iloperidone—ADRA2A—central nervous system—epilepsy syndrome	9.54e-05	0.0016	CbGeAlD
Iloperidone—ADRA2C—brain—epilepsy syndrome	9.49e-05	0.00159	CbGeAlD
Iloperidone—CYP2E1—central nervous system—epilepsy syndrome	9.33e-05	0.00157	CbGeAlD
Iloperidone—ADRA2A—cerebellum—epilepsy syndrome	9.32e-05	0.00156	CbGeAlD
Iloperidone—CYP2E1—cerebellum—epilepsy syndrome	9.12e-05	0.00153	CbGeAlD
Iloperidone—HTR2A—head—epilepsy syndrome	8.88e-05	0.00149	CbGeAlD
Iloperidone—HTR2A—nervous system—epilepsy syndrome	8.42e-05	0.00141	CbGeAlD
Iloperidone—HTR2A—central nervous system—epilepsy syndrome	8.11e-05	0.00136	CbGeAlD
Iloperidone—CYP2D6—head—epilepsy syndrome	8.09e-05	0.00136	CbGeAlD
Iloperidone—HTR2A—cerebellum—epilepsy syndrome	7.93e-05	0.00133	CbGeAlD
Iloperidone—CYP3A4—nervous system—epilepsy syndrome	7.8e-05	0.00131	CbGeAlD
Iloperidone—HRH1—brain—epilepsy syndrome	7.71e-05	0.00129	CbGeAlD
Iloperidone—CYP2D6—nervous system—epilepsy syndrome	7.67e-05	0.00129	CbGeAlD
Iloperidone—ADRA2A—brain—epilepsy syndrome	7.57e-05	0.00127	CbGeAlD
Iloperidone—Gefitinib—ALB—epilepsy syndrome	7.54e-05	0.0261	CrCbGaD
Iloperidone—CYP3A4—central nervous system—epilepsy syndrome	7.51e-05	0.00126	CbGeAlD
Iloperidone—CYP2E1—brain—epilepsy syndrome	7.41e-05	0.00124	CbGeAlD
Iloperidone—CYP2D6—central nervous system—epilepsy syndrome	7.39e-05	0.00124	CbGeAlD
Iloperidone—CYP2D6—cerebellum—epilepsy syndrome	7.22e-05	0.00121	CbGeAlD
Iloperidone—Gefitinib—ABCB1—epilepsy syndrome	7.19e-05	0.0249	CrCbGaD
Iloperidone—HTR2A—brain—epilepsy syndrome	6.44e-05	0.00108	CbGeAlD
Iloperidone—CYP2D6—brain—epilepsy syndrome	5.86e-05	0.000984	CbGeAlD
Iloperidone—Angiopathy—Pregabalin—epilepsy syndrome	5.34e-05	0.000338	CcSEcCtD
Iloperidone—Urinary tract disorder—Gabapentin—epilepsy syndrome	5.33e-05	0.000337	CcSEcCtD
Iloperidone—Body temperature increased—Felbamate—epilepsy syndrome	5.33e-05	0.000336	CcSEcCtD
Iloperidone—Diarrhoea—Propofol—epilepsy syndrome	5.32e-05	0.000336	CcSEcCtD
Iloperidone—Tremor—Valproic Acid—epilepsy syndrome	5.31e-05	0.000336	CcSEcCtD
Iloperidone—Dysuria—Topiramate—epilepsy syndrome	5.31e-05	0.000335	CcSEcCtD
Iloperidone—Mediastinal disorder—Pregabalin—epilepsy syndrome	5.31e-05	0.000335	CcSEcCtD
Iloperidone—Connective tissue disorder—Gabapentin—epilepsy syndrome	5.31e-05	0.000335	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	5.31e-05	0.000335	CcSEcCtD
Iloperidone—Urethral disorder—Gabapentin—epilepsy syndrome	5.29e-05	0.000334	CcSEcCtD
Iloperidone—Upper respiratory tract infection—Topiramate—epilepsy syndrome	5.28e-05	0.000333	CcSEcCtD
Iloperidone—Arrhythmia—Pregabalin—epilepsy syndrome	5.26e-05	0.000332	CcSEcCtD
Iloperidone—Pollakiuria—Topiramate—epilepsy syndrome	5.24e-05	0.000331	CcSEcCtD
Iloperidone—Anaemia—Valproic Acid—epilepsy syndrome	5.24e-05	0.000331	CcSEcCtD
Iloperidone—Feeling abnormal—Clonazepam—epilepsy syndrome	5.24e-05	0.000331	CcSEcCtD
Iloperidone—Paraesthesia—Lamotrigine—epilepsy syndrome	5.23e-05	0.00033	CcSEcCtD
Iloperidone—Erectile dysfunction—Topiramate—epilepsy syndrome	5.23e-05	0.00033	CcSEcCtD
Iloperidone—Body temperature increased—Zonisamide—epilepsy syndrome	5.21e-05	0.000329	CcSEcCtD
Iloperidone—Agitation—Valproic Acid—epilepsy syndrome	5.21e-05	0.000329	CcSEcCtD
Iloperidone—Asthenia—Fosphenytoin—epilepsy syndrome	5.2e-05	0.000329	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	5.2e-05	0.000329	CcSEcCtD
Iloperidone—Feeling abnormal—Phenytoin—epilepsy syndrome	5.2e-05	0.000329	CcSEcCtD
Iloperidone—Fatigue—Carbamazepine—epilepsy syndrome	5.2e-05	0.000328	CcSEcCtD
Iloperidone—Dyspnoea—Lamotrigine—epilepsy syndrome	5.19e-05	0.000328	CcSEcCtD
Iloperidone—Somnolence—Lamotrigine—epilepsy syndrome	5.18e-05	0.000327	CcSEcCtD
Iloperidone—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	5.17e-05	0.000327	CcSEcCtD
Iloperidone—Weight increased—Topiramate—epilepsy syndrome	5.17e-05	0.000326	CcSEcCtD
Iloperidone—Mental disorder—Pregabalin—epilepsy syndrome	5.16e-05	0.000326	CcSEcCtD
Iloperidone—Dizziness—Propofol—epilepsy syndrome	5.14e-05	0.000325	CcSEcCtD
Iloperidone—Diarrhoea—Levetiracetam—epilepsy syndrome	5.14e-05	0.000325	CcSEcCtD
Iloperidone—Weight decreased—Topiramate—epilepsy syndrome	5.14e-05	0.000324	CcSEcCtD
Iloperidone—Malnutrition—Pregabalin—epilepsy syndrome	5.13e-05	0.000324	CcSEcCtD
Iloperidone—Vertigo—Valproic Acid—epilepsy syndrome	5.09e-05	0.000322	CcSEcCtD
Iloperidone—Leukopenia—Valproic Acid—epilepsy syndrome	5.08e-05	0.000321	CcSEcCtD
Iloperidone—Asthenia—Vigabatrin—epilepsy syndrome	5.07e-05	0.000321	CcSEcCtD
Iloperidone—Eye disorder—Gabapentin—epilepsy syndrome	5.05e-05	0.000319	CcSEcCtD
Iloperidone—Tinnitus—Gabapentin—epilepsy syndrome	5.04e-05	0.000318	CcSEcCtD
Iloperidone—Dizziness—Midazolam—epilepsy syndrome	5.03e-05	0.000318	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	5.03e-05	0.000318	CcSEcCtD
Iloperidone—Body temperature increased—Clonazepam—epilepsy syndrome	5.02e-05	0.000317	CcSEcCtD
Iloperidone—Fatigue—Lamotrigine—epilepsy syndrome	5.02e-05	0.000317	CcSEcCtD
Iloperidone—Cardiac disorder—Gabapentin—epilepsy syndrome	5.01e-05	0.000317	CcSEcCtD
Iloperidone—Palpitations—Valproic Acid—epilepsy syndrome	5.01e-05	0.000317	CcSEcCtD
Iloperidone—Asthenia—Diazepam—epilepsy syndrome	4.99e-05	0.000316	CcSEcCtD
Iloperidone—Body temperature increased—Phenytoin—epilepsy syndrome	4.99e-05	0.000315	CcSEcCtD
Iloperidone—Nausea—Acetazolamide—epilepsy syndrome	4.97e-05	0.000314	CcSEcCtD
Iloperidone—Dizziness—Levetiracetam—epilepsy syndrome	4.97e-05	0.000314	CcSEcCtD
Iloperidone—Feeling abnormal—Carbamazepine—epilepsy syndrome	4.97e-05	0.000314	CcSEcCtD
Iloperidone—Body temperature increased—Oxcarbazepine—epilepsy syndrome	4.96e-05	0.000314	CcSEcCtD
Iloperidone—Diarrhoea—Fosphenytoin—epilepsy syndrome	4.96e-05	0.000314	CcSEcCtD
Iloperidone—Stomatitis—Topiramate—epilepsy syndrome	4.93e-05	0.000312	CcSEcCtD
Iloperidone—Muscle spasms—Pregabalin—epilepsy syndrome	4.93e-05	0.000311	CcSEcCtD
Iloperidone—Conjunctivitis—Topiramate—epilepsy syndrome	4.92e-05	0.000311	CcSEcCtD
Iloperidone—Rash—Propofol—epilepsy syndrome	4.9e-05	0.00031	CcSEcCtD
Iloperidone—Dermatitis—Propofol—epilepsy syndrome	4.9e-05	0.00031	CcSEcCtD
Iloperidone—Mediastinal disorder—Gabapentin—epilepsy syndrome	4.87e-05	0.000307	CcSEcCtD
Iloperidone—Diarrhoea—Vigabatrin—epilepsy syndrome	4.84e-05	0.000306	CcSEcCtD
Iloperidone—Asthenia—Felbamate—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Iloperidone—Vision blurred—Pregabalin—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Iloperidone—Arthralgia—Valproic Acid—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Iloperidone—Myalgia—Valproic Acid—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Iloperidone—Tremor—Pregabalin—epilepsy syndrome	4.8e-05	0.000303	CcSEcCtD
Iloperidone—Feeling abnormal—Lamotrigine—epilepsy syndrome	4.8e-05	0.000303	CcSEcCtD
Iloperidone—Rash—Midazolam—epilepsy syndrome	4.8e-05	0.000303	CcSEcCtD
Iloperidone—Dizziness—Fosphenytoin—epilepsy syndrome	4.8e-05	0.000303	CcSEcCtD
Iloperidone—Dermatitis—Midazolam—epilepsy syndrome	4.79e-05	0.000303	CcSEcCtD
Iloperidone—Epistaxis—Topiramate—epilepsy syndrome	4.77e-05	0.000302	CcSEcCtD
Iloperidone—Body temperature increased—Carbamazepine—epilepsy syndrome	4.76e-05	0.000301	CcSEcCtD
Iloperidone—Diarrhoea—Diazepam—epilepsy syndrome	4.76e-05	0.000301	CcSEcCtD
Iloperidone—Rash—Levetiracetam—epilepsy syndrome	4.74e-05	0.000299	CcSEcCtD
Iloperidone—Anaemia—Pregabalin—epilepsy syndrome	4.74e-05	0.000299	CcSEcCtD
Iloperidone—Dermatitis—Levetiracetam—epilepsy syndrome	4.73e-05	0.000299	CcSEcCtD
Iloperidone—Asthenia—Zonisamide—epilepsy syndrome	4.73e-05	0.000299	CcSEcCtD
Iloperidone—Mental disorder—Gabapentin—epilepsy syndrome	4.73e-05	0.000299	CcSEcCtD
Iloperidone—Dry mouth—Valproic Acid—epilepsy syndrome	4.72e-05	0.000298	CcSEcCtD
Iloperidone—Agitation—Pregabalin—epilepsy syndrome	4.71e-05	0.000298	CcSEcCtD
Iloperidone—Malnutrition—Gabapentin—epilepsy syndrome	4.7e-05	0.000297	CcSEcCtD
Iloperidone—Dizziness—Vigabatrin—epilepsy syndrome	4.68e-05	0.000295	CcSEcCtD
Iloperidone—Confusional state—Valproic Acid—epilepsy syndrome	4.67e-05	0.000295	CcSEcCtD
Iloperidone—Oedema—Valproic Acid—epilepsy syndrome	4.63e-05	0.000292	CcSEcCtD
Iloperidone—Nausea—Propofol—epilepsy syndrome	4.62e-05	0.000292	CcSEcCtD
Iloperidone—Diarrhoea—Felbamate—epilepsy syndrome	4.61e-05	0.000291	CcSEcCtD
Iloperidone—Vertigo—Pregabalin—epilepsy syndrome	4.61e-05	0.000291	CcSEcCtD
Iloperidone—Body temperature increased—Lamotrigine—epilepsy syndrome	4.6e-05	0.000291	CcSEcCtD
Iloperidone—Dizziness—Diazepam—epilepsy syndrome	4.6e-05	0.000291	CcSEcCtD
Iloperidone—Infection—Valproic Acid—epilepsy syndrome	4.6e-05	0.00029	CcSEcCtD
Iloperidone—Leukopenia—Pregabalin—epilepsy syndrome	4.59e-05	0.00029	CcSEcCtD
Iloperidone—Rash—Fosphenytoin—epilepsy syndrome	4.57e-05	0.000289	CcSEcCtD
Iloperidone—Dermatitis—Fosphenytoin—epilepsy syndrome	4.57e-05	0.000289	CcSEcCtD
Iloperidone—Asthenia—Clonazepam—epilepsy syndrome	4.56e-05	0.000288	CcSEcCtD
Iloperidone—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.54e-05	0.000287	CcSEcCtD
Iloperidone—Palpitations—Pregabalin—epilepsy syndrome	4.53e-05	0.000286	CcSEcCtD
Iloperidone—Asthenia—Phenytoin—epilepsy syndrome	4.53e-05	0.000286	CcSEcCtD
Iloperidone—Nausea—Midazolam—epilepsy syndrome	4.52e-05	0.000286	CcSEcCtD
Iloperidone—Muscle spasms—Gabapentin—epilepsy syndrome	4.52e-05	0.000286	CcSEcCtD
Iloperidone—Tachycardia—Valproic Acid—epilepsy syndrome	4.52e-05	0.000285	CcSEcCtD
Iloperidone—Diarrhoea—Zonisamide—epilepsy syndrome	4.51e-05	0.000285	CcSEcCtD
Iloperidone—Asthenia—Oxcarbazepine—epilepsy syndrome	4.51e-05	0.000285	CcSEcCtD
Iloperidone—Urinary tract disorder—Topiramate—epilepsy syndrome	4.49e-05	0.000283	CcSEcCtD
Iloperidone—Connective tissue disorder—Topiramate—epilepsy syndrome	4.46e-05	0.000282	CcSEcCtD
Iloperidone—Nausea—Levetiracetam—epilepsy syndrome	4.46e-05	0.000282	CcSEcCtD
Iloperidone—Rash—Vigabatrin—epilepsy syndrome	4.46e-05	0.000282	CcSEcCtD
Iloperidone—Dizziness—Felbamate—epilepsy syndrome	4.46e-05	0.000281	CcSEcCtD
Iloperidone—Dermatitis—Vigabatrin—epilepsy syndrome	4.45e-05	0.000281	CcSEcCtD
Iloperidone—Urethral disorder—Topiramate—epilepsy syndrome	4.45e-05	0.000281	CcSEcCtD
Iloperidone—Vision blurred—Gabapentin—epilepsy syndrome	4.43e-05	0.00028	CcSEcCtD
Iloperidone—Tremor—Gabapentin—epilepsy syndrome	4.4e-05	0.000278	CcSEcCtD
Iloperidone—Rash—Diazepam—epilepsy syndrome	4.39e-05	0.000277	CcSEcCtD
Iloperidone—Dermatitis—Diazepam—epilepsy syndrome	4.38e-05	0.000277	CcSEcCtD
Iloperidone—Arthralgia—Pregabalin—epilepsy syndrome	4.36e-05	0.000276	CcSEcCtD
Iloperidone—Myalgia—Pregabalin—epilepsy syndrome	4.36e-05	0.000276	CcSEcCtD
Iloperidone—Dizziness—Zonisamide—epilepsy syndrome	4.36e-05	0.000276	CcSEcCtD
Iloperidone—Diarrhoea—Clonazepam—epilepsy syndrome	4.35e-05	0.000275	CcSEcCtD
Iloperidone—Anaemia—Gabapentin—epilepsy syndrome	4.34e-05	0.000275	CcSEcCtD
Iloperidone—Hypotension—Valproic Acid—epilepsy syndrome	4.32e-05	0.000273	CcSEcCtD
Iloperidone—Asthenia—Carbamazepine—epilepsy syndrome	4.32e-05	0.000273	CcSEcCtD
Iloperidone—Agitation—Gabapentin—epilepsy syndrome	4.32e-05	0.000273	CcSEcCtD
Iloperidone—Diarrhoea—Phenytoin—epilepsy syndrome	4.32e-05	0.000273	CcSEcCtD
Iloperidone—Nausea—Fosphenytoin—epilepsy syndrome	4.31e-05	0.000272	CcSEcCtD
Iloperidone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.3e-05	0.000271	CcSEcCtD
Iloperidone—Dry mouth—Pregabalin—epilepsy syndrome	4.27e-05	0.00027	CcSEcCtD
Iloperidone—Rash—Felbamate—epilepsy syndrome	4.25e-05	0.000268	CcSEcCtD
Iloperidone—Eye disorder—Topiramate—epilepsy syndrome	4.25e-05	0.000268	CcSEcCtD
Iloperidone—Dermatitis—Felbamate—epilepsy syndrome	4.24e-05	0.000268	CcSEcCtD
Iloperidone—Tinnitus—Topiramate—epilepsy syndrome	4.24e-05	0.000268	CcSEcCtD
Iloperidone—Vertigo—Gabapentin—epilepsy syndrome	4.22e-05	0.000267	CcSEcCtD
Iloperidone—Confusional state—Pregabalin—epilepsy syndrome	4.22e-05	0.000267	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.22e-05	0.000266	CcSEcCtD
Iloperidone—Cardiac disorder—Topiramate—epilepsy syndrome	4.22e-05	0.000266	CcSEcCtD
Iloperidone—Leukopenia—Gabapentin—epilepsy syndrome	4.21e-05	0.000266	CcSEcCtD
Iloperidone—Dizziness—Clonazepam—epilepsy syndrome	4.2e-05	0.000266	CcSEcCtD
Iloperidone—Nausea—Vigabatrin—epilepsy syndrome	4.2e-05	0.000265	CcSEcCtD
Iloperidone—Oedema—Pregabalin—epilepsy syndrome	4.18e-05	0.000264	CcSEcCtD
Iloperidone—Asthenia—Lamotrigine—epilepsy syndrome	4.18e-05	0.000264	CcSEcCtD
Iloperidone—Dizziness—Phenytoin—epilepsy syndrome	4.17e-05	0.000264	CcSEcCtD
Iloperidone—Rash—Zonisamide—epilepsy syndrome	4.16e-05	0.000263	CcSEcCtD
Iloperidone—Infection—Pregabalin—epilepsy syndrome	4.16e-05	0.000263	CcSEcCtD
Iloperidone—Paraesthesia—Valproic Acid—epilepsy syndrome	4.16e-05	0.000263	CcSEcCtD
Iloperidone—Palpitations—Gabapentin—epilepsy syndrome	4.15e-05	0.000262	CcSEcCtD
Iloperidone—Dermatitis—Zonisamide—epilepsy syndrome	4.15e-05	0.000262	CcSEcCtD
Iloperidone—Dizziness—Oxcarbazepine—epilepsy syndrome	4.15e-05	0.000262	CcSEcCtD
Iloperidone—Nausea—Diazepam—epilepsy syndrome	4.13e-05	0.000261	CcSEcCtD
Iloperidone—Dyspnoea—Valproic Acid—epilepsy syndrome	4.13e-05	0.000261	CcSEcCtD
Iloperidone—Diarrhoea—Carbamazepine—epilepsy syndrome	4.12e-05	0.00026	CcSEcCtD
Iloperidone—Angiopathy—Topiramate—epilepsy syndrome	4.12e-05	0.00026	CcSEcCtD
Iloperidone—Somnolence—Valproic Acid—epilepsy syndrome	4.11e-05	0.00026	CcSEcCtD
Iloperidone—Nervous system disorder—Pregabalin—epilepsy syndrome	4.1e-05	0.000259	CcSEcCtD
Iloperidone—Mediastinal disorder—Topiramate—epilepsy syndrome	4.09e-05	0.000259	CcSEcCtD
Iloperidone—Tachycardia—Pregabalin—epilepsy syndrome	4.08e-05	0.000258	CcSEcCtD
Iloperidone—Rash—Clonazepam—epilepsy syndrome	4.01e-05	0.000253	CcSEcCtD
Iloperidone—Dermatitis—Clonazepam—epilepsy syndrome	4e-05	0.000253	CcSEcCtD
Iloperidone—Arthralgia—Gabapentin—epilepsy syndrome	4e-05	0.000253	CcSEcCtD
Iloperidone—Myalgia—Gabapentin—epilepsy syndrome	4e-05	0.000253	CcSEcCtD
Iloperidone—Nausea—Felbamate—epilepsy syndrome	4e-05	0.000253	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4e-05	0.000252	CcSEcCtD
Iloperidone—Fatigue—Valproic Acid—epilepsy syndrome	3.99e-05	0.000252	CcSEcCtD
Iloperidone—Dizziness—Carbamazepine—epilepsy syndrome	3.99e-05	0.000252	CcSEcCtD
Iloperidone—Diarrhoea—Lamotrigine—epilepsy syndrome	3.98e-05	0.000252	CcSEcCtD
Iloperidone—Rash—Phenytoin—epilepsy syndrome	3.98e-05	0.000251	CcSEcCtD
Iloperidone—Mental disorder—Topiramate—epilepsy syndrome	3.98e-05	0.000251	CcSEcCtD
Iloperidone—Dermatitis—Phenytoin—epilepsy syndrome	3.98e-05	0.000251	CcSEcCtD
Iloperidone—Rash—Oxcarbazepine—epilepsy syndrome	3.96e-05	0.00025	CcSEcCtD
Iloperidone—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.96e-05	0.00025	CcSEcCtD
Iloperidone—Malnutrition—Topiramate—epilepsy syndrome	3.95e-05	0.00025	CcSEcCtD
Iloperidone—Nausea—Zonisamide—epilepsy syndrome	3.92e-05	0.000247	CcSEcCtD
Iloperidone—Dry mouth—Gabapentin—epilepsy syndrome	3.91e-05	0.000247	CcSEcCtD
Iloperidone—Hypotension—Pregabalin—epilepsy syndrome	3.91e-05	0.000247	CcSEcCtD
Iloperidone—Confusional state—Gabapentin—epilepsy syndrome	3.87e-05	0.000244	CcSEcCtD
Iloperidone—Dizziness—Lamotrigine—epilepsy syndrome	3.85e-05	0.000243	CcSEcCtD
Iloperidone—Oedema—Gabapentin—epilepsy syndrome	3.84e-05	0.000242	CcSEcCtD
Iloperidone—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.81e-05	0.000241	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.81e-05	0.000241	CcSEcCtD
Iloperidone—Infection—Gabapentin—epilepsy syndrome	3.81e-05	0.000241	CcSEcCtD
Iloperidone—Muscle spasms—Topiramate—epilepsy syndrome	3.8e-05	0.00024	CcSEcCtD
Iloperidone—Rash—Carbamazepine—epilepsy syndrome	3.8e-05	0.00024	CcSEcCtD
Iloperidone—Dermatitis—Carbamazepine—epilepsy syndrome	3.8e-05	0.00024	CcSEcCtD
Iloperidone—Nausea—Clonazepam—epilepsy syndrome	3.78e-05	0.000239	CcSEcCtD
Iloperidone—Nervous system disorder—Gabapentin—epilepsy syndrome	3.76e-05	0.000238	CcSEcCtD
Iloperidone—Paraesthesia—Pregabalin—epilepsy syndrome	3.76e-05	0.000237	CcSEcCtD
Iloperidone—Nausea—Phenytoin—epilepsy syndrome	3.75e-05	0.000237	CcSEcCtD
Iloperidone—Tachycardia—Gabapentin—epilepsy syndrome	3.74e-05	0.000237	CcSEcCtD
Iloperidone—Dyspnoea—Pregabalin—epilepsy syndrome	3.73e-05	0.000236	CcSEcCtD
Iloperidone—Nausea—Oxcarbazepine—epilepsy syndrome	3.73e-05	0.000236	CcSEcCtD
Iloperidone—Vision blurred—Topiramate—epilepsy syndrome	3.73e-05	0.000235	CcSEcCtD
Iloperidone—Somnolence—Pregabalin—epilepsy syndrome	3.72e-05	0.000235	CcSEcCtD
Iloperidone—Tremor—Topiramate—epilepsy syndrome	3.71e-05	0.000234	CcSEcCtD
Iloperidone—Rash—Lamotrigine—epilepsy syndrome	3.67e-05	0.000232	CcSEcCtD
Iloperidone—Dermatitis—Lamotrigine—epilepsy syndrome	3.67e-05	0.000232	CcSEcCtD
Iloperidone—Body temperature increased—Valproic Acid—epilepsy syndrome	3.66e-05	0.000231	CcSEcCtD
Iloperidone—Anaemia—Topiramate—epilepsy syndrome	3.66e-05	0.000231	CcSEcCtD
Iloperidone—Agitation—Topiramate—epilepsy syndrome	3.63e-05	0.00023	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.61e-05	0.000228	CcSEcCtD
Iloperidone—Fatigue—Pregabalin—epilepsy syndrome	3.61e-05	0.000228	CcSEcCtD
Iloperidone—Hypotension—Gabapentin—epilepsy syndrome	3.59e-05	0.000226	CcSEcCtD
Iloperidone—Nausea—Carbamazepine—epilepsy syndrome	3.58e-05	0.000226	CcSEcCtD
Iloperidone—Vertigo—Topiramate—epilepsy syndrome	3.55e-05	0.000224	CcSEcCtD
Iloperidone—Leukopenia—Topiramate—epilepsy syndrome	3.54e-05	0.000224	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.5e-05	0.000221	CcSEcCtD
Iloperidone—Palpitations—Topiramate—epilepsy syndrome	3.5e-05	0.000221	CcSEcCtD
Iloperidone—Nausea—Lamotrigine—epilepsy syndrome	3.46e-05	0.000219	CcSEcCtD
Iloperidone—Feeling abnormal—Pregabalin—epilepsy syndrome	3.45e-05	0.000218	CcSEcCtD
Iloperidone—Paraesthesia—Gabapentin—epilepsy syndrome	3.45e-05	0.000218	CcSEcCtD
Iloperidone—Dyspnoea—Gabapentin—epilepsy syndrome	3.42e-05	0.000216	CcSEcCtD
Iloperidone—Somnolence—Gabapentin—epilepsy syndrome	3.41e-05	0.000215	CcSEcCtD
Iloperidone—Myalgia—Topiramate—epilepsy syndrome	3.37e-05	0.000213	CcSEcCtD
Iloperidone—Arthralgia—Topiramate—epilepsy syndrome	3.37e-05	0.000213	CcSEcCtD
Iloperidone—Asthenia—Valproic Acid—epilepsy syndrome	3.32e-05	0.00021	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.31e-05	0.000209	CcSEcCtD
Iloperidone—Fatigue—Gabapentin—epilepsy syndrome	3.31e-05	0.000209	CcSEcCtD
Iloperidone—Body temperature increased—Pregabalin—epilepsy syndrome	3.31e-05	0.000209	CcSEcCtD
Iloperidone—Dry mouth—Topiramate—epilepsy syndrome	3.29e-05	0.000208	CcSEcCtD
Iloperidone—Confusional state—Topiramate—epilepsy syndrome	3.25e-05	0.000206	CcSEcCtD
Iloperidone—Oedema—Topiramate—epilepsy syndrome	3.23e-05	0.000204	CcSEcCtD
Iloperidone—Infection—Topiramate—epilepsy syndrome	3.21e-05	0.000203	CcSEcCtD
Iloperidone—Diarrhoea—Valproic Acid—epilepsy syndrome	3.17e-05	0.0002	CcSEcCtD
Iloperidone—Nervous system disorder—Topiramate—epilepsy syndrome	3.17e-05	0.0002	CcSEcCtD
Iloperidone—Feeling abnormal—Gabapentin—epilepsy syndrome	3.16e-05	0.0002	CcSEcCtD
Iloperidone—Tachycardia—Topiramate—epilepsy syndrome	3.15e-05	0.000199	CcSEcCtD
Iloperidone—Dizziness—Valproic Acid—epilepsy syndrome	3.06e-05	0.000193	CcSEcCtD
Iloperidone—Body temperature increased—Gabapentin—epilepsy syndrome	3.03e-05	0.000192	CcSEcCtD
Iloperidone—Hypotension—Topiramate—epilepsy syndrome	3.02e-05	0.000191	CcSEcCtD
Iloperidone—Asthenia—Pregabalin—epilepsy syndrome	3e-05	0.00019	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.94e-05	0.000186	CcSEcCtD
Iloperidone—Rash—Valproic Acid—epilepsy syndrome	2.92e-05	0.000184	CcSEcCtD
Iloperidone—Dermatitis—Valproic Acid—epilepsy syndrome	2.92e-05	0.000184	CcSEcCtD
Iloperidone—Paraesthesia—Topiramate—epilepsy syndrome	2.9e-05	0.000183	CcSEcCtD
Iloperidone—Dyspnoea—Topiramate—epilepsy syndrome	2.88e-05	0.000182	CcSEcCtD
Iloperidone—Somnolence—Topiramate—epilepsy syndrome	2.87e-05	0.000181	CcSEcCtD
Iloperidone—Diarrhoea—Pregabalin—epilepsy syndrome	2.86e-05	0.000181	CcSEcCtD
Iloperidone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.79e-05	0.000176	CcSEcCtD
Iloperidone—Fatigue—Topiramate—epilepsy syndrome	2.78e-05	0.000176	CcSEcCtD
Iloperidone—Dizziness—Pregabalin—epilepsy syndrome	2.77e-05	0.000175	CcSEcCtD
Iloperidone—Asthenia—Gabapentin—epilepsy syndrome	2.75e-05	0.000174	CcSEcCtD
Iloperidone—Nausea—Valproic Acid—epilepsy syndrome	2.75e-05	0.000174	CcSEcCtD
Iloperidone—Feeling abnormal—Topiramate—epilepsy syndrome	2.66e-05	0.000168	CcSEcCtD
Iloperidone—Rash—Pregabalin—epilepsy syndrome	2.64e-05	0.000167	CcSEcCtD
Iloperidone—Dermatitis—Pregabalin—epilepsy syndrome	2.64e-05	0.000167	CcSEcCtD
Iloperidone—Diarrhoea—Gabapentin—epilepsy syndrome	2.63e-05	0.000166	CcSEcCtD
Iloperidone—Body temperature increased—Topiramate—epilepsy syndrome	2.55e-05	0.000161	CcSEcCtD
Iloperidone—Dizziness—Gabapentin—epilepsy syndrome	2.54e-05	0.00016	CcSEcCtD
Iloperidone—Nausea—Pregabalin—epilepsy syndrome	2.49e-05	0.000157	CcSEcCtD
Iloperidone—Rash—Gabapentin—epilepsy syndrome	2.42e-05	0.000153	CcSEcCtD
Iloperidone—Dermatitis—Gabapentin—epilepsy syndrome	2.42e-05	0.000153	CcSEcCtD
Iloperidone—Asthenia—Topiramate—epilepsy syndrome	2.32e-05	0.000146	CcSEcCtD
Iloperidone—Nausea—Gabapentin—epilepsy syndrome	2.28e-05	0.000144	CcSEcCtD
Iloperidone—Diarrhoea—Topiramate—epilepsy syndrome	2.21e-05	0.00014	CcSEcCtD
Iloperidone—Dizziness—Topiramate—epilepsy syndrome	2.13e-05	0.000135	CcSEcCtD
Iloperidone—Rash—Topiramate—epilepsy syndrome	2.04e-05	0.000129	CcSEcCtD
Iloperidone—Dermatitis—Topiramate—epilepsy syndrome	2.03e-05	0.000128	CcSEcCtD
Iloperidone—Nausea—Topiramate—epilepsy syndrome	1.92e-05	0.000121	CcSEcCtD
Iloperidone—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.47e-06	1.54e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.47e-06	1.54e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.47e-06	1.54e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—APOE—epilepsy syndrome	1.47e-06	1.54e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	1.46e-06	1.53e-05	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—AKT1—epilepsy syndrome	1.45e-06	1.52e-05	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	1.45e-06	1.52e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.45e-06	1.52e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TSC2—epilepsy syndrome	1.44e-06	1.52e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AGT—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—APOE—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—KDR—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—CASP3—epilepsy syndrome	1.44e-06	1.51e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.43e-06	1.51e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	1.43e-06	1.5e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	1.43e-06	1.5e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—CASP3—epilepsy syndrome	1.42e-06	1.5e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	1.41e-06	1.48e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—APOE—epilepsy syndrome	1.41e-06	1.48e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.41e-06	1.48e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.41e-06	1.48e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.4e-06	1.47e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	1.4e-06	1.47e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—JUN—epilepsy syndrome	1.39e-06	1.46e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—JUN—epilepsy syndrome	1.39e-06	1.46e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	1.39e-06	1.46e-05	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	1.39e-06	1.45e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—KDR—epilepsy syndrome	1.38e-06	1.45e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—JUN—epilepsy syndrome	1.38e-06	1.45e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1.38e-06	1.45e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.38e-06	1.45e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.37e-06	1.44e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	1.37e-06	1.44e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—RELA—epilepsy syndrome	1.37e-06	1.44e-05	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	1.36e-06	1.43e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.36e-06	1.43e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.36e-06	1.43e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	1.36e-06	1.43e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.36e-06	1.43e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—MMP9—epilepsy syndrome	1.36e-06	1.42e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.36e-06	1.42e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	1.35e-06	1.42e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—TH—epilepsy syndrome	1.35e-06	1.42e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.35e-06	1.42e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—RELA—epilepsy syndrome	1.35e-06	1.42e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.35e-06	1.42e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—MMP9—epilepsy syndrome	1.35e-06	1.41e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	1.34e-06	1.41e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.34e-06	1.41e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.34e-06	1.41e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.34e-06	1.41e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.33e-06	1.4e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.33e-06	1.4e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.33e-06	1.4e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—JUN—epilepsy syndrome	1.33e-06	1.4e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.33e-06	1.4e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.33e-06	1.39e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	1.33e-06	1.39e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	1.32e-06	1.39e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.32e-06	1.38e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—AKT1—epilepsy syndrome	1.32e-06	1.38e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	1.31e-06	1.38e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.31e-06	1.38e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.31e-06	1.37e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.31e-06	1.37e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.3e-06	1.36e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	1.3e-06	1.36e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.29e-06	1.35e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.28e-06	1.34e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.27e-06	1.33e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	1.26e-06	1.33e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—POMC—epilepsy syndrome	1.26e-06	1.32e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	1.26e-06	1.32e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—SRC—epilepsy syndrome	1.25e-06	1.31e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—SRC—epilepsy syndrome	1.25e-06	1.31e-05	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.25e-06	1.31e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—SRC—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—POMC—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.24e-06	1.3e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.23e-06	1.29e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.23e-06	1.29e-05	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.23e-06	1.29e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.23e-06	1.29e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	1.23e-06	1.29e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	1.22e-06	1.28e-05	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—VEGFA—epilepsy syndrome	1.22e-06	1.28e-05	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	1.22e-06	1.28e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—POMC—epilepsy syndrome	1.21e-06	1.27e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.21e-06	1.27e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	1.21e-06	1.27e-05	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.21e-06	1.27e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—JUN—epilepsy syndrome	1.2e-06	1.26e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—SRC—epilepsy syndrome	1.2e-06	1.26e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.19e-06	1.25e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CCL2—epilepsy syndrome	1.19e-06	1.25e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—JUN—epilepsy syndrome	1.18e-06	1.24e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.18e-06	1.24e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.17e-06	1.23e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	1.17e-06	1.23e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.17e-06	1.23e-05	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	1.16e-06	1.22e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.16e-06	1.21e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	1.15e-06	1.21e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	1.15e-06	1.21e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	1.14e-06	1.2e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	1.13e-06	1.19e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.13e-06	1.19e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.13e-06	1.19e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.13e-06	1.18e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—ALB—epilepsy syndrome	1.13e-06	1.18e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	1.12e-06	1.17e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	1.12e-06	1.17e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.12e-06	1.17e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.12e-06	1.17e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.11e-06	1.17e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.11e-06	1.17e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.1e-06	1.16e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.1e-06	1.15e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	1.09e-06	1.15e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.09e-06	1.14e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SRC—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	1.13e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—FGF2—epilepsy syndrome	1.07e-06	1.13e-05	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.07e-06	1.13e-05	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.07e-06	1.12e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.06e-06	1.12e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SRC—epilepsy syndrome	1.06e-06	1.11e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.06e-06	1.11e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	1.06e-06	1.11e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.05e-06	1.1e-05	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.05e-06	1.1e-05	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TH—epilepsy syndrome	1.05e-06	1.1e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.04e-06	1.1e-05	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.04e-06	1.09e-05	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	1.03e-06	1.09e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.03e-06	1.09e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	1.03e-06	1.08e-05	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—RELA—epilepsy syndrome	1.02e-06	1.07e-05	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.01e-06	1.06e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1e-06	1.05e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	9.99e-07	1.05e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	9.99e-07	1.05e-05	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	9.98e-07	1.05e-05	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	9.97e-07	1.05e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—RELA—epilepsy syndrome	9.96e-07	1.05e-05	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	9.96e-07	1.05e-05	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	9.88e-07	1.04e-05	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	9.86e-07	1.03e-05	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MTOR—epilepsy syndrome	9.77e-07	1.03e-05	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	9.74e-07	1.02e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	9.72e-07	1.02e-05	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	9.69e-07	1.02e-05	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	9.42e-07	9.89e-06	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	9.42e-07	9.88e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	9.33e-07	9.79e-06	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.26e-07	9.72e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	9.26e-07	9.72e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	9.26e-07	9.72e-06	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	9.24e-07	9.7e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	9.21e-07	9.67e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	9.18e-07	9.63e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	9.16e-07	9.61e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	9.08e-07	9.53e-06	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.07e-07	9.52e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—JUN—epilepsy syndrome	9.06e-07	9.51e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	9.02e-07	9.46e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CASP3—epilepsy syndrome	8.99e-07	9.43e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	8.97e-07	9.41e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	8.96e-07	9.4e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	8.92e-07	9.36e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—JUN—epilepsy syndrome	8.9e-07	9.34e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AGT—epilepsy syndrome	8.85e-07	9.28e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	8.82e-07	9.25e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.79e-07	9.23e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—JUN—epilepsy syndrome	8.73e-07	9.16e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.73e-07	9.16e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	8.72e-07	9.16e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	8.67e-07	9.1e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—APOE—epilepsy syndrome	8.67e-07	9.1e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	8.66e-07	9.08e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.61e-07	9.04e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	8.55e-07	8.97e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—MMP9—epilepsy syndrome	8.49e-07	8.91e-06	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.43e-07	8.85e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	8.41e-07	8.83e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	8.39e-07	8.81e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	8.37e-07	8.79e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	8.35e-07	8.76e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AKT1—epilepsy syndrome	8.24e-07	8.65e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SRC—epilepsy syndrome	8.13e-07	8.53e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	8.11e-07	8.51e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.01e-07	8.41e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	8e-07	8.39e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SRC—epilepsy syndrome	7.98e-07	8.38e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	7.92e-07	8.31e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	7.89e-07	8.28e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SRC—epilepsy syndrome	7.83e-07	8.22e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.79e-07	8.18e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.79e-07	8.17e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	7.77e-07	8.16e-06	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AKT1—epilepsy syndrome	7.77e-07	8.16e-06	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	7.76e-07	8.15e-06	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AKT1—epilepsy syndrome	7.71e-07	8.09e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	7.65e-07	8.03e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VEGFA—epilepsy syndrome	7.63e-07	8e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—POMC—epilepsy syndrome	7.45e-07	7.82e-06	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	7.43e-07	7.8e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	7.28e-07	7.64e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.09e-07	7.44e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.01e-07	7.36e-06	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—AKT1—epilepsy syndrome	6.85e-07	7.19e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.83e-07	7.17e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ALB—epilepsy syndrome	6.79e-07	7.13e-06	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	6.69e-07	7.02e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.69e-07	7.02e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—AKT1—epilepsy syndrome	6.66e-07	6.99e-06	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	6.6e-07	6.93e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	5.94e-07	6.23e-06	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	5.75e-07	6.04e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.75e-07	6.03e-06	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	5.72e-07	6.01e-06	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	5.57e-07	5.84e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—AKT1—epilepsy syndrome	5.41e-07	5.68e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.24e-07	5.5e-06	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	5.05e-07	5.3e-06	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	4.97e-07	5.22e-06	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—AKT1—epilepsy syndrome	4.97e-07	5.21e-06	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	4.96e-07	5.2e-06	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—AKT1—epilepsy syndrome	4.95e-07	5.2e-06	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AKT1—epilepsy syndrome	4.87e-07	5.11e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.58e-07	4.81e-06	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	4.52e-07	4.75e-06	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.52e-07	3.7e-06	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.98e-07	3.13e-06	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.3e-07	2.42e-06	CbGpPWpGaD
